Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Copyright Nasdaq. Minimum 15 minutes delayed.

Press Releases
CHF Solutions, Inc. Enters the German Market
July 12, 2018

EDEN PRAIRIE, Minn. , July 12, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH , a business solutions resource based in Germany . HSC-Medical will serve as a fulfillment house and

Read More
CHF Solutions, Inc. Announces Closing of Common Stock Offering
July 3, 2018

EDEN PRAIRIE, Minn. , July 03, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of its previously-announced underwritten public offering of 2,547,169 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of $5.4 million ,

Read More
CHF Solutions, Inc. Announces Pricing of Common Stock Offering
June 29, 2018

EDEN PRAIRIE, Minn. , June 29, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of 2,214,930 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of approximately $4.7 million prior to

Read More
View all press releases »

Events & Presentations

View all events & presentations »